Godlike Productions - Reply to Thread

Users Online Now: 1,864 (Who's On?)	Visitors Today: 985,912
Pageviews Today: 1,708,705	Threads Today: 667	Posts Today: 13,059
06:45 PM

REPLY TO THREAD

Subject Vaccines’ Alum Adjuvant Path to Brain Found

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message A new study adds a major link in the association of aluminum adjuvants in vaccines with neurological disorders. It demonstrates the pathway along which aluminum in vaccine adjuvants is transferred from the injection site to the brain, where it persists indefinitely. They have also identified a likely carrier and a means by which the process occurs.

The study is exhaustive, eliminating a wide array of options that might mitigate against their findings. They also focused on two groups to determine if their findings indicate that they’re at particular risk. They include newborns and people with a certain genetic variant. On top of that, the elderly may be at significantly higher risk for aluminum adjuvant-induced neurotoxic harm.

[link to gaia-health.com]

Pictures (click to insert)





\| Next Page >>